Vimarsana
Biggest News Aggregation in the World

Page 3 - Neil Butt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neil Butt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neil Butt Today - Breaking & Trending Today

SanegeneBio and Orbit join forces to establish targeting peptides - Vimarsana News

SanegeneBio and Orbit join forces to establish targeting peptides

Agreement covers cell-based studies, with an additional option to further develop screening activities - News - PharmaTimes

Orbit Discovery and SanegeneBio collaborate to identify targeting peptides for RNAi drugs - Vimarsana News

Orbit Discovery and SanegeneBio collaborate to identify targeting peptides for RNAi drugs

Orbit Discovery Limited (Orbit), a leader in the discovery of therapeutic peptide hits, today announced it has entered into a Master Service Agreement with SanegeneBio Inc.

Smart support for Peptide Drug Discovery Platform - Vimarsana News

Smart support for Peptide Drug Discovery Platform

Biopharmaceutical company Orbit Discovery has been awarded a £472,000 Smart grant by Innovate UK, to facilitate the implementation of droplet-based microfluidics for cell-based functional screening to advance the discovery of peptide therapeutic candidates. Click to read more...

Agreement paves way for joint Peptide Discovery and Optimisation Partnership - Vimarsana News

Agreement paves way for joint Peptide Discovery and Optimisation Partnership

Peptide technology company Orbit Discovery has announced a partnership with WuXi AppTec that will see the combination of its peptide discovery platform and experience with the Chinese organisation’s downstream capabilities as a leading global provider of R&D and manufacturing services provision for the pharmaceutical and healthcare industry. Click to read more...

Orbit Discovery and WuXi AppTec sign agreement - Vimarsana News

Orbit Discovery and WuXi AppTec sign agreement

WuXi AppTec’s development and manufacturing platform will enable Orbit to generate peptides at small or large scale